The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1241
August 14, 2006
View Complete Issue         Table of Contents 2019 
VariZIG for Prophylaxis After Exposure to Varicella
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
VariZIG for Prophylaxis After Exposure to Varicella
August 14, 2006 (Issue: 1241)
The US manufacturer of varicella zoster immune globulin (VZIG; Massachusetts Public Health Biologic Laboratories, Boston, MA) recently discontinued its production. A Canadian formulation, VariZIG (Varicella Zoster Immune Globulin [Human] - Cangene...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: VariZIG for Prophylaxis After Exposure to Varicella
Article code: 1241d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.